Eduardo Oliver, PhD
Researcher in Cardiovascular Pharmacology in Madrid, Spain
I am a Research Fellow in the Translational Laboratory for Cardiovascular Imaging and Therapy at the Spanish National Center for Cardiovascular Research (CNIC) in Madrid (Spain). My current research focuses on the study and better understanding of the mechanism of action of beta-blockers both at the cellular and molecular level, and its consequences at anatomical and physiological level in models of cardiovascular diseases.
I studied Pharmacy (2004) and completed my PhD in Pharmacology in 2010 at the University of Valencia (Spain). My thesis focused on the role of adrenergic receptors and GRKs in the genesis, maintenance and development of cardiovascular diseases such essential hypertension or terminal heart failure. I have overseas experience at the University of Rouen (France) during my degree, and at the University of Glasgow (Scotland, UK) during my PhD.
After my PhD, I moved to Imperial College London were I worked as a Research Associate within the Centre for Pharmacology & Therapeutics. During this time, I described the zinc transporter ZIP12 as a new potential drug target for the treatment of pulmonary hypertension, a serious heart and lung disease triggered by chronic hypoxia (Nature, 2015). Thanks to my research, I was awarded in 2016with the 'EPHAR Young Investigator Award'.
Besides my research experience, I am an External Lecturer of the Master in Research and Rational Use of Medicines at the University of Valencia and contributing author at the scientific blog Mapping ignorance. I belong to several scientific societies such as the Spanish Society of Pharmacology where I have been its first chair of the Young Pharmacologist committee (2010-2015), I am member of the Zinc-UK and the ZincNet EU group, and Fellow of the Pulmonary Vascular Research Institute (PVRI).
During the time in the UK, I played a significant role in the conception and development of the Society of Spanish Researchers in the UK (SRUK/CERU). I am a founding member and since its formal foundation in 2012, I have been part of the board of directors and various committees, some of which I have launched. I became President between 2015-2016, year in which numerous initiatives were developed. I am also one of the components of the Science Policy committee that developed and presented the Report of Recommendations on R&D in Spain for the General Elections of 2015, I have participated in public debates and written opinion articles in the press about science policy and diplomacy.